{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:54:38Z","timestamp":1790258078784,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Korea government","doi-asserted-by":"publisher","award":["2014R1A2A2A01003079"],"award-info":[{"award-number":["2014R1A2A2A01003079"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Korea government","doi-asserted-by":"publisher","award":["2016R1A5A2012284"],"award-info":[{"award-number":["2016R1A5A2012284"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health & Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["HI12C0021"],"award-info":[{"award-number":["HI12C0021"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.neuropharm.2016.09.014","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T19:32:38Z","timestamp":1473967958000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"PA","title":["Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism"],"prefix":"10.1016","volume":"113","author":[{"given":"Ji-Woon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Seung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson Luck T.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ah","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Jung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seol-Heui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1764-6740","authenticated-orcid":false,"given":"Chan Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.09.014_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0091-3057(96)00331-0","article-title":"The role of the striatum in the mouse in behavioral sensitization to amphetamine","volume":"56","author":"Bedingfield","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib3","article-title":"Memantine in the treatment of executive function deficits in adults with ADHD: a pilot-randomized double-blind controlled clinical trial","author":"Biederman","year":"2014","journal-title":"J.\u00a0Atten. Disord."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/104454602762599871","article-title":"Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series","volume":"12","author":"Carrey","year":"2002","journal-title":"J.\u00a0Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","article-title":"Oxidative stress in autism","volume":"13","author":"Chauhan","year":"2006","journal-title":"Pathophysiology"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm.3193","article-title":"Progress toward treatments for synaptic defects in autism","volume":"19","author":"Delorme","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2005.08.008","article-title":"Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects","volume":"390","author":"Feng","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1203\/00006450-200210000-00023","article-title":"Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats","volume":"52","author":"Feng","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","article-title":"Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism","volume":"68","author":"Gandal","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib11","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/tp.2012.69","article-title":"GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction","volume":"2","author":"Gandal","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib12","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/00001756-199607290-00007","article-title":"Metabolism of agmatine into urea but not into nitric oxide in rat brain","volume":"7","author":"Gilad","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.wnr.0000192739.38653.aa","article-title":"Release of tritiated agmatine from spinal synaptosomes","volume":"17","author":"Goracke-Postle","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine : metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1542\/pir.35-2-62","article-title":"The clinician's guide to autism","volume":"35","author":"Harrington","year":"2014","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10571-013-0014-9","article-title":"Translational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells","volume":"34","author":"Jeon","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib17","first-page":"2473","article-title":"Assessment of social interaction behaviors","volume":"48","author":"Kaidanovich-Beilin","year":"2011","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib18","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1523\/JNEUROSCI.4082-03.2004","article-title":"Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity","volume":"24","author":"Kang","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnmol.2015.00017","article-title":"Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors","volume":"8","author":"Kang","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0006-8993(97)00221-7","article-title":"The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine","volume":"757","author":"Karler","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib21","doi-asserted-by":"crossref","first-page":"e104927","DOI":"10.1371\/journal.pone.0104927","article-title":"Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder","volume":"124","author":"Kim","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12035-013-8535-2","article-title":"Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring","volume":"49","author":"Kim","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib25","first-page":"1","article-title":"Overexpression of telomerase reverse transcriptase induces autism-like excitatory phenotypes in mice","author":"Kim","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neubiorev.2010.02.004","article-title":"The neurobiology of repetitive behavior: of mice","volume":"35","author":"Langen","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib27","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1162\/jocn.2009.21305","article-title":"Ketamine modulates theta and gamma oscillations","volume":"22","author":"Lazarewicz","year":"2010","journal-title":"J.\u00a0Cogn. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1476-5381.2010.00707.x","article-title":"Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations","volume":"160","author":"Ludolph","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/neuro.01.1.1.006.2007","article-title":"The intense world syndrome\u2013an alternative hypothesis for autism","volume":"1","author":"Markram","year":"2007","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fnhum.2010.00224","article-title":"The intense world theory - a unifying theory of the neurobiology of autism","volume":"4","author":"Markram","year":"2010","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib32","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1007\/s00213-014-3479-4","article-title":"Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit\/hyperactivity disorder","volume":"231","author":"Miller","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2009.00304.x","article-title":"Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential","volume":"157","author":"Mony","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1176\/appi.ajp.163.2.316","article-title":"Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study","volume":"163","author":"Moore","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","article-title":"Excitatory\/Inhibitory balance and circuit homeostasis in autism spectrum disorders","volume":"87","author":"Nelson","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1196\/annals.1304.009","article-title":"Neuropharmacokinetic and dynamic studies of agmatine (decarboxylated arginine)","volume":"1009","author":"Nguyen","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuron.2012.01.034","article-title":"Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome","volume":"77","author":"Osterweil","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/j.1471-4159.2007.04843.x","article-title":"A\u00a0role for polyamines in retinal ganglion cell excitotoxic death","volume":"103","author":"Pernet","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100 years in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12640-013-9376-5","article-title":"Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage","volume":"24","author":"Piletz","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1304.007","article-title":"Agmatine crosses the blood-brain barrier","volume":"1009","author":"Piletz","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0091-3057(02)01081-X","article-title":"Selective blockade of spontaneous motor stereotypy via intrastriatal pharmacological manipulation","volume":"74","author":"Presti","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib45","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1054-3589(08)60834-0","article-title":"Agmatine: a novel neurotransmitter?","volume":"42","author":"Reis","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(98)00466-2","article-title":"Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells","volume":"250","author":"Reis","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib48","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism\u2013a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neubiorev.2003.08.010","article-title":"Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder\u2013the spontaneously hypertensive rat","volume":"27","author":"Russell","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib53","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1046\/j.1471-4159.1996.67041761.x","article-title":"Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine","volume":"67","author":"Sastre","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbr.2012.06.032","article-title":"NMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders","volume":"234","author":"Saunders","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pbb.2003.11.016","article-title":"Anticonvulsive effect of agmatine in mice","volume":"77","author":"Su","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fnins.2015.00313","article-title":"Characterizing autism spectrum disorders by key biochemical pathways","volume":"9","author":"Subramanian","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neuropharm.2005.11.022","article-title":"Effect of the attention deficit\/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat","volume":"50","author":"Swanson","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib60","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biopsych.2003.09.001","article-title":"High nitric oxide production in autistic disorder: a possible role for interferon-gamma","volume":"55","author":"Sweeten","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib61","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nbd.2008.10.010","article-title":"Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome","volume":"33","author":"Tervonen","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signalling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2013.00019","article-title":"Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses","volume":"6","author":"Won","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib65","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(24)37988-1","article-title":"Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons","volume":"288","author":"Yang","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.09.014_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature10360","article-title":"Neocortical excitation\/inhibition balance in information processing and social dysfunction","volume":"477","author":"Yizhar","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.09.014_bib67","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11064-012-0724-2","article-title":"Downregulating the canonical Wnt\/beta-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress","volume":"37","author":"Zhang","year":"2012","journal-title":"Neurochem. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816303987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816303987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:06:31Z","timestamp":1749582391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816303987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":65,"alternative-id":["S0028390816303987"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}